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T Cell Receptor-Vb Analysis Identi®es a Dominant
CD60+ CD26± CD49d± T Cell Clone in the Peripheral Blood
of SeÂzary Syndrome Patients
To the Editor:
Clonality assessment of T cell leukemias has widely been detected
by several molecular techniques such as southern blotting analysis
and polymerase chain reaction (PCR), mostly on T cell receptor
(TCR)-g genes, but also TCR-b due to its larger recombination
variable region repertoire. TCR-Vb ¯uorescence-activated cell
sorter (FACS) analysis has also been used recently for the assessment
of clonality in T cell malignancies (Gorochov et al, 1995; Bigler et al,
1996; Rappl et al, 2001).
In this study we employed FACS TCR-Vb repertoire analysis in
13 patients with SeÂzary syndrome (SS), using a panel of 21
monoclonal antibodies (MoAb) covering 70% of the entire human
Vb repertoire. Ten of these patients showed a single Vb
population, ranging from 67 to 99%, of circulating CD4+ T cells.
This restricted reactivity concerned several TCR-Vb families;
however, expansion of Vb 2 was observed in four cases and Vb 5.1
in two cases (Table I).
To establish if the expanded TCR-Vb T cell population seen by
¯ow cytometry was due to a homogeneous T cell clone, we further
analyzed the diversity of the T cell repertoire through molecular
techniques such as spectratyping and direct sequencing. We took
advantage of the previous FACS analysis (Fig 1A) to run single
speci®c reverse transcription±PCR on RNA extracted from each
sample. We were able to show speci®c ampli®cation for the
corresponding TCR-Vb genes by either agarose gel analysis or by
spectratyping (Fig 1B,C). The use of spectratyping easily con-
®rmed the clonality within the Vb-positive clone, leaving out the
possibility of a polyclonal population, as this technique measures
the size heterogeneity of the TCR hypervariable CDR3 region.
The spectratypes obtained from normal repertoires are complex and
show a Gaussian distribution of eight or more bands that represent
the different lengths of the respective TCR VDJ regions. By
contrast, CDR3 size analysis from patients affected by SS contained
only one dominant peak, which is highly suggestive of a clonal
expansion (Fig 1B) (Bagot et al, 1998). The PCR product was
further sequenced and compared with a TCR-Vb database (Folch
et al, 2000) con®rming that they were speci®cally rearranged Vb
(Fig 1D). These molecular approaches con®rmed the clonality of
the restricted population identi®ed in 10 of 13 patients by FACS
analysis and allowed also the possibility to design speci®c primers
for each individual patient. We did not observe multiple reactions
to TCR-Vb MoAb.
We performed FACS Vb analysis in the 10 positive patients
6 mo after the ®rst analysis. In two cases we observed a marked
reduction in circulating TCR-Vb reactive cells associated with a
clinical improvement (clearing of palmoplantar hyperkeratosis, 90%
reduction of erythroderma, loss of dermal edema, scaling,
lymphoadenopathy, and disappearance of pruritus) during treat-
ment with extracorporeal photopheresis (on two consecutive days,
monthly) and a2a recombinant interferon (Fig 2). These data
clearly indicate that Vb FACS analysis might be useful for the
measurement of the tumor burden. A major advantage of ¯ow
cytometry TCR-Vb analysis over molecular analysis is that the Vb
restricted T cell population can quantitatively be monitored during
and after therapy, as shown in Fig 2, and be applied also in
laboratories lacking molecular biology techniques.
We then took advantage of the speci®c Vb reactivity of these
neoplastic T cells in SS to de®ne the phenotype of these cells. We
used several markers that have been associated with these malignant
cells (Dummer et al, 1999; Bernengo et al, 2001; Jones et al, 2001;
Rappl et al, 2001). We found that the expression of CD60, the lack
of CD26, and, to a lesser extent, the lack of CD49d were invariably
associated with the expanded Vb clones. Heterogeneity was instead
observed in the expression of CD7 and CLA among different cases
(see Table I), as previously described (Bernengo et al, 2001;
Dummer et al, 1999; Jones et al, 2001), whereas other surface
antigens studied, such as CD27, CD28, CD70, and CD103, were
not signi®cantly associated with the clonal T cells (not shown).
CD45R0 was expressed by all T cells despite their Vb positivity.
When normal individuals were studied for the CD4+ CD26±
CD49d± CD60+ phenotype, we found such phenotype in less than
5% of circulating T cells. Thus, the expansion of such a population
in the peripheral blood of SS patients might have a functional
signi®cance. It is well known, in fact, that neoplastic cells of SS
patients do not grow in vitro, either spontaneously or when
challenged with standard proliferative stimuli (McCusker et al,
1997; Harwix et al, 2001). By contrast, in vitro challenge of T cells
from patients with cutaneous T cell lymphoma with anti-CD60
results in frank activation of these cells suggesting that this antigen-
independent activation pathway might also be important in vivo
(Hansen et al, 1993). On the other hand, the simultaneous lack of
CD26 and CD49d surface antigens might be associated with the
loss of epidermotropism of cutaneous T cell lymphoma clones in
patients who have hematologic involvement, as both these
molecules exert adhesion activities with the extracellular matrix.
Peripheral T cells migrating through a layer of endothelial cells on
collagen, express very high levels of CD26 (Masuyama et al, 1992),
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which is known to exert adhesion activity with ®bronectin and
collagen (Kameoka et al, 1993). Concomitantly, a4b1 (CD49d/
CD29) is also involved in this pathway, as is the receptor for ligands
such as vascular cell adhesion molecule-1 and for ®bronectin (as
well as CD26). Thus, the concomitant shedding of both CD26 and
CD49d in circulating T cells, might be associated with the inability
of these clonal T cells to migrate through the vessel wall and ®rmly
adhere to the extracellular matrix spaces, thus becoming predom-
inant in the peripheral blood.
In three cases the TCR-Vb panel was unable to identify the
neoplastic clone as already observed by some authors (Gorochov
et al, 1995; Bigler et al, 1996). In these cases, however, a high
percentage (> 93%) of T cells with CD60+ CD49d± CD26±
phenotype was also observed, in contrast to less than 5% of T
cells derived from 10 healthy donors. In these three patients if
all the MoAb against Vb were mixed together and probed in a
single reaction to circulating CD3+ CD4+, cells they recognized
less than 5% of T cells compared with 70% observed in normal
subjects. Thus, this unusual high unreactivity of CD4+ circu-
lating T cells, associated with the presence of a high percentage
of CD60+ CD49d± CD26± cells, might be considered indirect
evidence of a large T cell population with single, although
unidenti®ed or unreactive, Vb domain. A similar observation of
such high unreactive Vb population (less than 20% of all CD3+
T cells) was recently reported by Langerak et al (2001) in 16 of
the 47 cases of a series of mature TCR-ab T cell proliferations
Table I. TCR-Vb analysis and differentiation/activation and homing-related molecules expression in the peripheral blood
Patient
no.
TCR-Vb CD3+CD4+ Within CD4,1 TCR-Vb+ cells (percentages)
Vb family % Absolute number CD CD CD60+ CD49+ CLA+
1 2 92 3162 91.5 3 88 0 25
2 5,1 67 1514 1.5 0.5 64 2 50
3 13.6 98 2348 0,5 0 61 22 2
4 5.1 68.5 2748 1 0 66 44 12
5 12 88 9685 100 0 28 0 22
6 2 94 1128 6 4 97 3 37
7 22 78 2500 13 0 70.5 2 27
8 17 91 2915 60 7 93 1 2
9 2 90.5 6131 1,5 0 75 6 30
10 2 83 4946 1 0 89 1.5 2
11 Failed ± ± 2a 1.5a 98.3a 1.5a 0.4a
12 Failed ± ± 1a 2.3a 92.7a 1a 1.4a
13 Failed ± ± 2a 3a 94a 3a 13a
Healthy donors
[10]
82 6 6.5 72.1 6 3.5 18.6 6 7.2 80.5 6 8.7 6.9 6 3.5
aCalculated within TCRVbunreactive T cells (see text).
Figure 1. Identi®cation of the dominant TCR-Vb12 from patient 5. (A) Multiparameter ¯ow cytometry on peripheral blood lymphocytes
showing that nearly all CD4+ T cells are TCR-Vb12+. (B) CDR3 size pro®le of TCR-Vb12 transcripts from healthy donor (left) showing Gaussian
distribution of eight band, and from patient 5 (right) showing only one dominant peak. (C) Reverse transcription±PCR with speci®c primers for
TCR-Vb12. The quality of the cDNA sample was determined by ampli®cation of the housekeeping GAPDH gene. (D) Sequencing of the CDR3
region of the TCR-Vb ampli®ed from RNA compared with the GenBank database.
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studied with a similar panel of MoAb, and also considered by
these authors as indirect proof for the presence of a large
``clonal'' T cell population.
In conclusion, this study shows that: (i) TCR-Vb repertoire
analysis is a reliable marker to be used for the identi®cation and
quanti®cation of tumor cells in the peripheral blood; (ii) the
identi®cation of the molecular signature of the tumor cell is highly
simpli®ed by the FACS analysis, with speci®c TCR-Vb MoAb; if
this identi®cation is successful, then only one PCR reaction can be
performed to identify and characterize the CDR3 region, that is
actually the most speci®c genetic marker of the neoplastic T cells,
and certainly a potential important tool for measuring the tumor
burden; and (iii) the CD4+ CD60+ CD26± CD49d±immuno-
phenotype is strongly associated with the dominant T cell clone
in the peripheral blood of patients with SS.
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Structure of the 5¢ Portion of the Human Plakoglobin Gene
To the Editor:
Plakoglobin, a member of the arm-repeat family of proteins, binds
to classical cadherins and desmosomal cadherins (Zhurinsky et al,
2000). Mutations in plakoglobin cause Naxos disease, which
involves arrhythmogenic right ventricular cardiomyopathy,
palmoplantar keratoderma, and woolly hair (McKoy et al, 2000).
Plakoglobin also is required for the cell separation effect of
pemphigus autoantibodies (Caldelari et al, 2001).
In recent studies, we found a discrepancy between the exon/
intron structure of the human plakoglobin gene as described in
Whittock et al (2000) and in the public (NCBI) and Celera
human genome databases. Using sequence information from
plakoglobin cDNA, Whittock et al ampli®ed virtually the entire
plakoglobin gene by polymerase chain reaction (PCR). They
found the gene to contain 13 exons spanning approximately
17 kb of genomic DNA. In particular, they found that the 5¢-
most 328 bp of cDNA existed in the genome as a single exon,
as shown in Fig 1 (``single exon''). In contrast, the plakoglobin
gene sequence in the Celera database is annotated and indicates
that this 328 bp sequence is split into two exons separated by a
14.7 kb intron (see Fig 1, ``two exons''). The plakoglobin
sequence in the public database is incomplete (exons 2±13 are
not present) and has not yet been annotated, but exon 1 and
» 3.8 kb of intron 1 (as shown in Fig 1, ``two exons'') are
present and are virtually identical to the corresponding
sequences in the Celera database. (The only exception is a
» 300 bp region within intron 1, about 2.7 kb downstream of
exon 1, which differs in sequence between the Celera and
public databases.)
We veri®ed the ``two exons'' structure by performing PCR
on human genomic DNA (kindly provided by Richard
Wenstrup, MD, Children's Hospital, Cincinnati, OH) with a
series of primer pairs, as shown in Fig 1. All primer pairs
generated fragments with sizes that were consistent with the
``two exon'' structure, and inconsistent with the ``single exon''
structure. Further, one PCR product (U2:D2) was sequenced
on both strands and matched the database sequences at the
intron±exon 2 junction. Based on this con®rmation of the
database sequence, we propose that the exons of the
plakoglobin gene be renumbered 1±14.
Whittock et al (2000) had con®rmed the single exon structure by
PCR ampli®cation using upstream and downstream primers (A and
B in Fig 1) within ``exon 1.'' Primers corresponding to the 5¢- and
3¢-ends of ``exon 1'' should not have yielded a PCR product if
these sequences were separated by 14.7 kB; however, the Whittock
et al upstream primer A (Fig 1) spanned the junction between the
split portions of the exon and, in retrospect, it seems likely that
the 3¢ portion of this oligonucleotide primed synthesis from within
the actual exon 2, misleadingly suggesting these sequences consti-
tuted a single exon.
The presence of the 14.7 kb intron between exons 1 and 2 is
clearly signi®cant for analyses of the effects of plakoglobin
mutations and for studies of plakoglobin gene regulation. For
example, Potter et al (2001) noted that the immediate 5¢ ¯anking
region of the plakoglobin gene (5¢ in Fig 1) has a high CpG
dinucleotide content and demonstrated that expression of plako-
globin is downregulated in some cell lines as a result of
hypermethylation in this region. Analysis of the intron sequence
shows that the 1 kb immediately downstream of the ®rst exon has
an exceptionally high CpG content, strongly supporting the
suggestion of Potter et al (2001). Furthermore, regulogram analysis
(Jegga et al, in press) of the plakoglobin gene reveals a signi®cant cis-
acting element cluster within the 14.7 kb intron (Fig 2). In
particular, there is a 300 bp block of sequence 1 kb into the ®rst
intron that contains a cluster of cis-regulatory elements, which is
highly conserved in human and mouse plakoglobin genes. The
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Figure 1. Structure of the 5¢-end of the human plakoglobin gene.
The ``single exon'' model for exon 1 shown at the top is based on
evidence presented in Whittock et al (2000). The ``two exons'' model is
based on sequence information in the Celera human genome database.
Exon bp numbers are derived from Whittock et al (2000) and Potter et al
(2001); bp 1 represents the proximal transcription start site mapped by
5¢-RACE (Potter et al, 2001). The translation start site (arrow with
ATG) is located at bp 120. 5¢ ¯anking sequences (marked 5¢ in both
models) are identical in Whittock et al (2000), Potter et al (2001), and
both public and Celera databases. Arrows indicate upstream primers U2
(5¢-CAT GGT GAT GAT GTG GGA G-3¢), U3 (5¢-AGG TCA GAG
ATC CAA GCC-3¢), U4 (5¢-ATG ACC CTG ATG GAG CAG 3), U5
(5¢-GTG GAA GAG GAC TGG AGG-3¢) and downstream primers D1
(5¢-CTA CAA TCT GCC TCC TTT CAG-3¢), D2 (5¢-TAG TTA
GCA TGA GCT GTG C-3¢), and D3 (5¢-CTT GCT CAG ATC TCT
GGT TC-3¢), used in PCR reactions with human genomic DNA. A
and B signify primers used by Whittock et al (2000).
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